Literature DB >> 22157535

Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis.

Danilo B Fernandes1, Renata de Iracema P Ramos, Carolina Falcochio, Samira Apóstolos-Pereira, Dagoberto Callegaro, Mário Luiz Ribeiro Monteiro.   

Abstract

OBJECTIVE: To review the clinical characteristics of patients with neuromyelitis optica (NMO) and to compare their visual outcome with those of patients with optic neuritis (ON) and multiple sclerosis (MS).
METHODS: Thirty-three patients with NMO underwent neuro-ophthalmic evaluation, including automated perimetry along with 30 patients with MS. Visual function in both groups was compared overall and specifically for eyes after a single episode of ON.
RESULTS: Visual function and average visual field (VF) mean deviation were significantly worse in eyes of patients with NMO. After a single episode of ON, the VF was normal in only 2 of 36 eyes of patients with NMO compared to 17 of 35 eyes with MS (P < 0.001). The statistical analysis indicated that after a single episode of ON, the odds ratio for having NMO was 6.0 (confidence interval [CI]: 1.6-21.9) when VF mean deviation was worse than -20.0 dB while the odds ratio for having MS was 16.0 (CI: 3.6-68.7) when better than -3.0 dB.
CONCLUSION: Visual outcome was significantly worse in NMO than in MS. After a single episode of ON, suspicion of NMO should be raised in the presence of severe residual VF deficit with automated perimetry and lowered in the case of complete VF recovery.

Entities:  

Mesh:

Year:  2012        PMID: 22157535     DOI: 10.1097/WNO.0b013e31823a9ebc

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  21 in total

1.  Pattern electroretinogram in neuromyelitis optica and multiple sclerosis with or without optic neuritis and its correlation with FD-OCT and perimetry.

Authors:  Kenzo Hokazono; Ali S Raza; Maria K Oyamada; Donald C Hood; Mário L R Monteiro
Journal:  Doc Ophthalmol       Date:  2013-07-30       Impact factor: 2.379

2.  Optic neuritis in neuromyelitis optica.

Authors:  Marc H Levin; Jeffrey L Bennett; A S Verkman
Journal:  Prog Retin Eye Res       Date:  2013-03-30       Impact factor: 21.198

3.  Differences in Clinical Features of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in White and Asian Race.

Authors:  Tanyatuth Padungkiatsagul; John J Chen; Panitha Jindahra; Tetsuya Akaishi; Toshiyuki Takahashi; Ichiro Nakashima; Takayuki Takeshita; Heather E Moss
Journal:  Am J Ophthalmol       Date:  2020-07-15       Impact factor: 5.258

4.  Short-term effect of additional apheresis on visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica spectrum disorders.

Authors:  Sotaro Mori; Takuji Kurimoto; Kaori Ueda; Makoto Nakamura
Journal:  Jpn J Ophthalmol       Date:  2018-05-25       Impact factor: 2.447

5.  Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.

Authors:  John J Chen; Eoin P Flanagan; Jiraporn Jitprapaikulsan; Alfonso Sebastian S López-Chiriboga; James P Fryer; Jacqueline A Leavitt; Brian G Weinshenker; Andrew McKeon; Jan-Mendelt Tillema; Vanda A Lennon; W Oliver Tobin; B Mark Keegan; Claudia F Lucchinetti; Orhun H Kantarci; Collin M McClelland; Michael S Lee; Jeffrey L Bennett; Victoria S Pelak; Yanjun Chen; Gregory VanStavern; Ore-Ofe O Adesina; Eric R Eggenberger; Marie D Acierno; Dean M Wingerchuk; Paul W Brazis; Jessica Sagen; Sean J Pittock
Journal:  Am J Ophthalmol       Date:  2018-07-26       Impact factor: 5.258

6.  Association of race/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial.

Authors:  Heather E Moss; Weihua Gao; Laura J Balcer; Charlotte E Joslin
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

Review 7.  Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.

Authors:  Jeffrey L Bennett
Journal:  J Neuroophthalmol       Date:  2016-09       Impact factor: 3.042

Review 8.  The treatment of neuromyelitis optica.

Authors:  Markus C Kowarik; John Soltys; Jeffrey L Bennett
Journal:  J Neuroophthalmol       Date:  2014-03       Impact factor: 3.042

Review 9.  Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.

Authors:  Joseph Kuchling; Alexander U Brandt; Friedemann Paul; Michael Scheel
Journal:  EPMA J       Date:  2017-07-25       Impact factor: 6.543

10.  Visual field characteristics in neuromyelitis optica in absence of and after one episode of optic neuritis.

Authors:  Harold Merle; Stéphane Olindo; Séverine Jeannin; Rabih Hage; Angélique Donnio; Raymond Richer; Philippe Cabre
Journal:  Clin Ophthalmol       Date:  2013-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.